| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5278684
Max Phase: Preclinical
Molecular Formula: C12H8N4O2S2
Molecular Weight: 304.36
Associated Items:
Representations
Canonical SMILES: O=[N+]([O-])c1cccc(Nc2nc(-c3nccs3)cs2)c1
Standard InChI: InChI=1S/C12H8N4O2S2/c17-16(18)9-3-1-2-8(6-9)14-12-15-10(7-20-12)11-13-4-5-19-11/h1-7H,(H,14,15)
Standard InChI Key: OQCJVLJMTBCUCO-UHFFFAOYSA-N
Associated Targets(Human)
Cytochrome P450 1B1 1148 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 304.36 | Molecular Weight (Monoisotopic): 304.0089 | AlogP: 3.92 | #Rotatable Bonds: 4 |
| Polar Surface Area: 80.95 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.46 | CX Basic pKa: 1.68 | CX LogP: 3.77 | CX LogD: 3.77 |
| Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.58 | Np Likeness Score: -2.56 |
References
| 1. Mao J, Wang D, Xu P, Wang Y, Zhang H, Wang S, Xu F, Wang J, Zhang F.. (2022) Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells., 65 (24.0): [PMID:36512763] [10.1021/acs.jmedchem.2c01306] |
Source
Source(1):